Gemfibrozil: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
No edit summary
mNo edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{subpages}}
{{subpages}}
[[Image:Gemfibrozil structure.jpg|right|thumb|200px|{{#ifexist:Template:Gemfibrozil structure.jpg/credit|{{Gemfibrozil structure.jpg/credit}}<br/>|}}Gemfibrozil.]]
{{Image|Gemfibrozil structure.jpg|right|200px|Gemfibrozil.}}  


'''Gemfibrozil''', or  5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid), is a [[Antilipemic agent|antilipemic ]] [[medication]] that lowers serum [[triglyceride]] levels, with variable effects on [[cholesterol]].  The [[VLDL]] fraction is preferentially lowered and LDL less so. Gemfibrozil can treat [[hypoalphalipoproteinemia]] by increasing the HDL subfractions HDL2 and HDL3, and [[apolipoprotein]]s A-I and A-II. Gemfibrozil is a [[fibric acid]] derivitive [[antilipemic agent]] similar to [[clofibrate]] that is used to treat [[hyperlipoproteinemia]] and supplimental therapy for type IIb [[hypercholesterolemia]]. Gemfibrozil increases lipoprotein triglyceride lipolysis by increasing the activity of extrahepatic [[lipoprotein lipase]]. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL.  
'''Gemfibrozil''', or  5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid), is a [[Antilipemic agent|antilipemic]] [[medication]] that lowers serum [[triglyceride]] levels, with variable effects on [[cholesterol]]. Gemfibrozil is a [[fibrate]] derivative similar to [[bezafibrate]], [[clofibrate]], and [[procetofen]] (fenofibrate).
 
Gemfibrozil lowers the [[VLDL]] fraction more than it lowers the LDL fraction. Gemfibrozil increases lipoprotein triglyceride lipolysis by increasing the activity of extrahepatic [[lipoprotein lipase]]. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL. Gemfibrozil can treat [[hypoalphalipoproteinemia]] by increasing the HDL subfractions HDL2 and HDL3, and [[apolipoprotein]]s A-I and A-II.  It is supplemental therapy for type IIb [[hypercholesterolemia]].  


== Drug Interactions ==
== Drug Interactions ==
Gemfibrozil increases the [[anticoagulant]] effects of [[anisindione]], [[dicumarol]], [[acenocoumarol]] and [[warfarin]].  There is an increased risk of [[myopathy]]/[[rhaddomyolysis]] when gemfibrizol is taken with the cholesterol lowering statin drugs [[atorvastatin]] (Lipitor), [[cerivastatin]], [[fluvastatin]] (Lescol), [[lovastatin]], [[pravastatin]] (Pravachol), and [[simvastatin]] (Vytorin).  Gemfibrizol increases the effects and toxicity of [[pioglitazone]], [[rosiglitazone]] and [[repaglinide]].  The statin [[rosuvastatin]] (Crestor) may increase the effect of gemfibrizol, and gemfibrizol decreases the effects of [[ursodiol]].
Gemfibrozil increases the [[anticoagulant]] effects of [[anisindione]], [[dicumarol]], [[acenocoumarol]] and [[warfarin]].  There is an increased risk of [[myopathy]]/[[rhaddomyolysis]] when gemfibrizol is taken with the cholesterol lowering statin drugs [[atorvastatin]] (Lipitor), [[cerivastatin]], [[fluvastatin]] (Lescol), [[lovastatin]], [[pravastatin]] (Pravachol), and [[simvastatin]] (Vytorin).  Gemfibrizol increases the effects and toxicity of [[pioglitazone]], [[rosiglitazone]] and [[repaglinide]].  The statin [[rosuvastatin]] (Crestor) may increase the effect of gemfibrizol, and gemfibrizol decreases the effects of [[ursodiol]].
   
   
== Brand Names ==
== Brand Names ==
<div class= style="-moz-column-count:3; column-count:3;">
<div class= style="-moz-column-count:3; column-count:3;">
Line 32: Line 33:


== External Links ==
== External Links ==
{{CZMed}}
{{CZMed}}[[Category:Suggestion Bot Tag]]

Latest revision as of 17:00, 20 August 2024

This article is a stub and thus not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Gemfibrozil&printable=yes
This editable Main Article is under development and subject to a disclaimer.
(CC) Image: David E. Volk
Gemfibrozil.

Gemfibrozil, or 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid), is a antilipemic medication that lowers serum triglyceride levels, with variable effects on cholesterol. Gemfibrozil is a fibrate derivative similar to bezafibrate, clofibrate, and procetofen (fenofibrate).

Gemfibrozil lowers the VLDL fraction more than it lowers the LDL fraction. Gemfibrozil increases lipoprotein triglyceride lipolysis by increasing the activity of extrahepatic lipoprotein lipase. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL. Gemfibrozil can treat hypoalphalipoproteinemia by increasing the HDL subfractions HDL2 and HDL3, and apolipoproteins A-I and A-II. It is supplemental therapy for type IIb hypercholesterolemia.

Drug Interactions

Gemfibrozil increases the anticoagulant effects of anisindione, dicumarol, acenocoumarol and warfarin. There is an increased risk of myopathy/rhaddomyolysis when gemfibrizol is taken with the cholesterol lowering statin drugs atorvastatin (Lipitor), cerivastatin, fluvastatin (Lescol), lovastatin, pravastatin (Pravachol), and simvastatin (Vytorin). Gemfibrizol increases the effects and toxicity of pioglitazone, rosiglitazone and repaglinide. The statin rosuvastatin (Crestor) may increase the effect of gemfibrizol, and gemfibrizol decreases the effects of ursodiol.

Brand Names

  • Apo-Gemfibrozil
  • Bolutol
  • Cholespid
  • Decrelip
  • Fibratol
  • Fibrocit
  • Gemfibril
  • Gemfibromax
  • Gemlipid
  • Gen-Fibro
  • Genlip
  • Gevilon
  • Hipolixan
  • Jezil
  • Lipozid
  • Lipur
  • Lopid
  • Novo-Gemfibrozil
  • Nu-Gemfibrozil

External Links

The most up-to-date information about Gemfibrozil and other drugs can be found at the following sites.

Retrieved from "https://citizendium.org/wiki/index.php?title=Gemfibrozil&oldid=973052"